Accelerated TMS for Perinatal Depression
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT06968390
- Status
- Recruiting
Conditions
- Major Depressive Disorder
- Perinatal Depression
- Post Partum Depression
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- Transcranial Magnetic Stimulation — DEVICENon-invasive form of brain stimulation.
Study Details
We are studying a treatment for depression called accelerated Transcranial Magnetic Stimulation (TMS) among pregnant and postpartum individuals. TMS is a focal, non-invasive form of brain stimulation that is cleared by the Food and Drug Administration for depression. Typically, traditional TMS involves daily treatments for 6-8 weeks. In this study, we will offer an accelerated form of TMS that involves multiple daily treatments for 5 days.
Key Dates
- Start date
- Aug 5, 2025
- Status verified
- May 2025
- Primary completion
- Nov 30, 2026
- Completion
- Jan 1, 2027
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Open-label aiTBS for pregnant/postpartum individuals10 iTBS treatment sessions per day (18,000 pulses/day) for 5 consecutive days (90,000 pulses total) to the dorsolateral prefrontal cortex (DLPFC). In the unlikely event that a participant is late for an hourly treatment, then the treatment will be delayed accordingly. The minimum gap between treatments will be 25 minutes. Each iTBS treatment will consist of 60 cycles of 10 bursts of three pulses at 50 Hz delivered in 2-second trains (5 Hz) with an 8-second intertrain interval. Stimulation will be delivered at 90% resting motor threshold (rMT), adjusted for depth of the identified functional connectivity target or based on traditional scalp measurements.
Primary Outcome Measure
Tolerability as measured by ratings of the Client Satisfaction Questionnaire (CSQ-8) [ Time Frame: 1 month after treatment ]
Central Contacts
- Interventional Psychiatry Research Group617 525 3536
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Joseph J Taylor, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
By condition
By specialty
By research site
Related Studies
- Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar DisorderEARLY_PHASE1 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric PopulationsRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Neural Correlates of Stress and Perceived Control in Adolescent DepressionRecruiting · Mclean Hospital · Belmont, Massachusetts
- Peripheral Neuroimmune Mechanisms of HyperthermiaRecruiting · Massachusetts General Hospital · Boston, Massachusetts